• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA CCAT2 通过 miR-145/p70S6K1 和 p53 通路促进人食管癌细胞的放射抵抗。

lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR‑145/p70S6K1 and p53 pathway.

机构信息

Department of Radiation Therapy, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.

Department of Digestive Endoscopy, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.

出版信息

Int J Oncol. 2020 Jan;56(1):327-336. doi: 10.3892/ijo.2019.4929. Epub 2019 Dec 2.

DOI:10.3892/ijo.2019.4929
PMID:31789385
Abstract

The long non‑coding RNA colon cancer‑associated transcript 2 (CCAT2) is abnormally expressed in various types of malignant tumor tissues and considered to be an oncogene, including for esophageal cancer (EC). Radiotherapy is an important and widely used cancer treatment. However, some patients with EC do not respond to radiotherapy. This study was designed to investigate effects of CCAT2 expression on radiotherapy dynamics for EC cells and to explore underlying molecular mechanisms. Reverse transcription‑quantitative PCR was used to measure CCAT2 expression in EC tissues, normal esophageal mucosa, EC cells and normal human esophageal epithelial cells. TUNEL assays were used to assess the effect of CCAT2 on X‑ray‑induced apoptosis of EC cells. Protein expression was detected by western blot. CCAT2 was highly expressed in EC tissues and EC cells, and was negatively associated with radiotherapy efficacy in patients with EC. In vitro, knockdown of CCAT2 enhanced radiosensitivity of EC cells and promoted apoptosis by increasing Bax/Bcl2 and active‑caspase 3/caspase 3 following X‑ray treatment. In addition, CCAT2 negatively regulated miR‑145 and P70 ribosomal protein S6 kinase 1 (p70S6K1) expression, and inhibited phosphorylation of Akt, ERK and p70S6K1 in EC cells. After X‑ray treatment, CCAT2 negatively regulated protein levels of p53, P21 and c‑Myc. These results showed that CCAT2 promoted the radiotherapy resistance of EC cells via negative regulation of the miR‑145/p70S6K1 and the p53 signaling pathways and associated elements may be potential targets for improving the sensitivity of EC radiotherapy.

摘要

长链非编码 RNA 结肠癌相关转录物 2(CCAT2)在各种类型的恶性肿瘤组织中异常表达,被认为是一种癌基因,包括食管癌(EC)。放射治疗是一种重要且广泛应用的癌症治疗方法。然而,一些 EC 患者对放射治疗没有反应。本研究旨在探讨 CCAT2 表达对 EC 细胞放射动力学的影响及其潜在的分子机制。逆转录定量 PCR 用于测量 EC 组织、正常食管黏膜、EC 细胞和正常人食管上皮细胞中 CCAT2 的表达。TUNEL 测定法用于评估 CCAT2 对 EC 细胞 X 射线诱导凋亡的影响。蛋白质表达通过 Western blot 检测。CCAT2 在 EC 组织和 EC 细胞中高表达,与 EC 患者的放射治疗疗效呈负相关。在体外,CCAT2 敲低增强了 EC 细胞的放射敏感性,并通过增加 Bax/Bcl2 和 X 射线处理后活性 caspase-3/caspase-3 促进细胞凋亡。此外,CCAT2 负调控 miR-145 和 P70 核糖体蛋白 S6 激酶 1(p70S6K1)的表达,并抑制 EC 细胞中 Akt、ERK 和 p70S6K1 的磷酸化。X 射线处理后,CCAT2 负调控 p53、P21 和 c-Myc 的蛋白水平。这些结果表明,CCAT2 通过负调控 miR-145/p70S6K1 和 p53 信号通路及其相关元件促进 EC 细胞的放射抵抗,并且相关元素可能是提高 EC 放射治疗敏感性的潜在靶点。

相似文献

1
lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR‑145/p70S6K1 and p53 pathway.长链非编码 RNA CCAT2 通过 miR-145/p70S6K1 和 p53 通路促进人食管癌细胞的放射抵抗。
Int J Oncol. 2020 Jan;56(1):327-336. doi: 10.3892/ijo.2019.4929. Epub 2019 Dec 2.
2
Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy.长链非编码 RNA Rpph1 在食管癌中的价值及其对癌细胞放射敏感性的影响。
World J Gastroenterol. 2020 Apr 21;26(15):1775-1791. doi: 10.3748/wjg.v26.i15.1775.
3
Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.辐射诱导 NORAD 表达通过 EEPD1/ATR/Chk1 信号通路促进 ESCC 放疗抵抗,并抑制 pri-miR-199a1 的加工和 miR-199a-5p 的外泌体转移。
J Exp Clin Cancer Res. 2021 Sep 29;40(1):306. doi: 10.1186/s13046-021-02084-5.
4
lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.lncTUG1/miR-144-3p 通过竞争性调节 c-MET 影响食管鳞癌细胞的放射敏感性。
J Exp Clin Cancer Res. 2020 Jan 9;39(1):7. doi: 10.1186/s13046-019-1519-y.
5
MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/β-catenin pathway.microRNA-1275 通过调控 Wnt/β-catenin 通路诱导食管癌上皮间质转化实现放射增敏
J Cell Mol Med. 2020 Jan;24(1):747-759. doi: 10.1111/jcmm.14784. Epub 2019 Nov 15.
6
LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.LINC00657/miR-26a-5p/CKS2 ceRNA 网络通过 MDM2/p53/Bcl2/Bax 通路促进食管癌细胞的生长。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200525.
7
LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.长链非编码 RNA-TUSC7/miR-224 通过竞争性调节 DESC1 影响食管鳞癌细胞的化疗耐药性。
J Exp Clin Cancer Res. 2018 Mar 12;37(1):56. doi: 10.1186/s13046-018-0724-4.
8
Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.下调 HMGB1 表达对食管癌细胞的放射增敏作用。
Oncol Rep. 2019 Mar;41(3):1960-1970. doi: 10.3892/or.2018.6923. Epub 2018 Dec 10.
9
Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.长链非编码 RNA HAGLR 通过调节 LAMP3 作为 microRNA-143-5p 的海绵体调控食管癌上皮-间充质转化和转移潜能。
FASEB J. 2019 Sep;33(9):10490-10504. doi: 10.1096/fj.201802543RR. Epub 2019 Jul 15.
10
Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.Sine oculis homeobox homolog 3 的上调与食管癌的增殖、侵袭、迁移以及不良预后有关。
Anticancer Drugs. 2019 Jul;30(6):596-603. doi: 10.1097/CAD.0000000000000751.

引用本文的文献

1
Functions and mechanisms of long non-coding RNA in esophageal squamous cell carcinoma (Review).长链非编码RNA在食管鳞状细胞癌中的作用及机制(综述)
Oncol Lett. 2025 Jul 1;30(3):418. doi: 10.3892/ol.2025.15164. eCollection 2025 Sep.
2
CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies.CCAT2在胃肠道癌进展和转移中的作用:治疗策略的新靶点
Clin Exp Med. 2025 Jun 11;25(1):197. doi: 10.1007/s10238-025-01730-y.
3
Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications.
揭示微小RNA在食管癌中的作用:从发病机制到临床应用
Front Pharmacol. 2025 Jan 29;16:1532558. doi: 10.3389/fphar.2025.1532558. eCollection 2025.
4
MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2.微小 RNA-145-5p 通过 SENP2 调控的 ERK2 泛素化抑制乳腺癌的发生。
Cell Mol Life Sci. 2024 Nov 23;81(1):461. doi: 10.1007/s00018-024-05505-8.
5
Radioresistance and brain metastases: a review of the literature and applied perspective.放射抗性与脑转移瘤:文献综述及应用前景
Front Oncol. 2024 Oct 30;14:1477448. doi: 10.3389/fonc.2024.1477448. eCollection 2024.
6
LncRNA CCAT2 Knockdown Alleviates Pressure Overload or Ang II-Induced Cardiac Hypertrophy Via Disruption of the Wnt/β-Catenin Signaling.长链非编码 RNA CCAT2 敲低通过破坏 Wnt/β-连环蛋白信号减轻压力超负荷或 Ang II 诱导的心肌肥厚。
Arq Bras Cardiol. 2024 Oct;121(10):e20240181. doi: 10.36660/abc.20240181.
7
The Role of Long Noncoding RNAs (lncRNAs) in Esophageal Cancer Therapy Resistance and Metastasis.长链非编码RNA(lncRNAs)在食管癌治疗耐药性和转移中的作用
Biomedicines. 2024 Mar 15;12(3):660. doi: 10.3390/biomedicines12030660.
8
Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1.长链非编码RNA BBOX1-AS1通过稳定和激活磷酸果糖激酶1(PFK1)提高结直肠癌的放疗敏感性。
Transl Oncol. 2023 Oct;36:101751. doi: 10.1016/j.tranon.2023.101751. Epub 2023 Aug 4.
9
LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing.长链非编码 RNA CCAT2 通过调控 CD44 可变剪接促进转移性胃癌的恶性进展。
Cell Oncol (Dordr). 2023 Dec;46(6):1675-1690. doi: 10.1007/s13402-023-00835-4. Epub 2023 Jun 24.
10
The roles and mechanisms of the lncRNA-miRNA axis in the progression of esophageal cancer: a narrative review.长链非编码RNA-微小RNA轴在食管癌进展中的作用及机制:一项叙述性综述
J Thorac Dis. 2022 Nov;14(11):4545-4559. doi: 10.21037/jtd-22-1449.